Aditxt Holders Approve Share Issuances, Reverse Split Flexibility

An update from Aditxt ( (ADTX) ) is now available.

On February 13, 2026, Aditxt reconvened its special meeting of stockholders, originally held on January 30, 2026, with 33.39% of voting power present, and stockholders approved multiple proposals tied to Nasdaq Rule 5635(d) authorizing the issuance of common shares underlying Series A-1 and Series C-1 preferred stock and 2024 warrants, as well as the company’s 2025 Employee Stock Purchase Plan and a large increase in shares available under its 2021 Omnibus Equity Incentive Plan. Investors also backed a non-binding name change to bitXbio, Inc., granted the board wide discretion to execute a reverse stock split at ratios between 1-for-5 and 1-for-250 within a year, and approved the option to adjourn meetings to solicit more proxies, moves that collectively enhance Aditxt’s flexibility to manage dilution, maintain Nasdaq compliance and pursue future strategic or financing initiatives.

More about Aditxt

Aditxt, Inc. is a publicly traded company whose shares are listed on Nasdaq, and it manages its capital structure through various classes of convertible preferred stock, common stock purchase warrants and equity-based compensation plans. The company also maintains employee equity participation programs, including an omnibus equity incentive plan and an employee stock purchase plan, reflecting a capital markets-focused approach to financing and incentivizing its workforce.

Average Trading Volume: 2,748,303

Technical Sentiment Signal: Strong Sell

Current Market Cap: $387.1K

See more insights into ADTX stock on TipRanks’ Stock Analysis page.